Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07663747
What this trial is testing

Enfortumab Vedotin + Pembrolizumab Induction to Spare the Bladder in MIBC

Who this might be right for
Urothelial Bladder Cancer
The Netherlands Cancer Institute 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07337447
What this trial is testing

Trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control Arm in Second Line Treatment of Neuroendocrine Carcinoma of Gastro-enteropancreatic or Unknown Origin (REWENEC 01)

Who this might be right for
Carcinoma, Neuroendocrine
Hospices Civils de Lyon 122
Testing effectiveness (Phase 2)Ended earlyNCT00061958
What this trial is testing

Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the EsophagusStage III Esophageal CancerStage IV Esophageal Cancer
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Looking for participantsNCT06812858
What this trial is testing

PD-1 Inhibitors Maintenance for cHL Post-autoHCT

Who this might be right for
Hodgkin Lymphoma
St. Petersburg State Pavlov Medical University 83
Early research (Phase 1)Study completedNCT00630058
What this trial is testing

MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 20
Large-scale testing (Phase 3)UnknownNCT00002858
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 280
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06972758
What this trial is testing

Adjuvant Everolimus in High-Risk Hepatocellular Carcinoma After Curative Resection (SEVERANCE Trial)

Who this might be right for
CarcinomHepatocellular
Yonsei University 60
Testing effectiveness (Phase 2)Study completedNCT00863148
What this trial is testing

Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
MDSAMLALL+1 more
Nantes University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00243048
What this trial is testing

Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 70
Testing effectiveness (Phase 2)Ended earlyNCT00664378
What this trial is testing

Efficacy Study of CYT997 in Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
Gilead Sciences 5
Large-scale testing (Phase 3)Not Yet RecruitingNCT07072585
What this trial is testing

Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

Who this might be right for
Stage II T Lymphoblastic Leukemia/LymphomaStage III T Lymphoblastic Leukemia/LymphomaStage IV T Lymphoblastic Leukemia/Lymphoma+2 more
Children's Oncology Group 1,708
Testing effectiveness (Phase 2)UnknownNCT04780685
What this trial is testing

A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19

Who this might be right for
Covid19
Stemedica Cell Technologies, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT05353985
What this trial is testing

TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet

Who this might be right for
Celiac Disease
Takeda 153
Testing effectiveness (Phase 2)Study completedNCT02324985
What this trial is testing

Phase II Study of AP0302 5% Versus a Vehicle Comparator

Who this might be right for
PainDelayed Onset Muscle Soreness
Aponia Laboratories, Inc. 147
Testing effectiveness (Phase 2)UnknownNCT03766178
What this trial is testing

Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 45
Testing effectiveness (Phase 2)Study completedNCT02799485
What this trial is testing

SEphB4-HSA in Treating Patients With Kaposi Sarcoma

Who this might be right for
Skin Kaposi Sarcoma
AIDS Malignancy Consortium 23
Testing effectiveness (Phase 2)Study completedNCT00377585
What this trial is testing

Demonstrate the Superiority of the Immune Response of Adjuvanted Influenza Vaccine Induced in an Adult Population

Who this might be right for
Influenza
GlaxoSmithKline 3,350
Testing effectiveness (Phase 2)Active Not RecruitingNCT06185335
What this trial is testing

A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A

Who this might be right for
Hemophilia A
Biocad 50
Testing effectiveness (Phase 2)UnknownNCT05241899
What this trial is testing

A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Cancer

Who this might be right for
Gastric Cancer
The First Affiliated Hospital of Zhengzhou University 56
Testing effectiveness (Phase 2)Study completedNCT00101816
What this trial is testing

Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate

Who this might be right for
Chronic Myeloid LeukemiaBlast Crisis
Bristol-Myers Squibb 124
Next Page